Condition
Severe Nonproliferative Diabetic Retinopathy
Total Trials
4
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Unknown3
Withdrawn1
Clinical Trials (4)
Showing 4 of 4 trials
NCT02309502Not ApplicableWithdrawnPrimary
Panretinal Photo-stimulation in Proliferative Diabetic Retinopathy
NCT03863535Not ApplicableUnknownPrimary
PRP vs PRP+IVC for Severe nPDR
NCT01759121Not ApplicableUnknownPrimary
Safety and Effectiveness Study of 532nm Laser Subthreshold Panretinal Photocoagulation for Severe NPDR
NCT01790945Unknown
Diabetic Macular Edema and Diabetic Retinopathy Screening (TeleMed) With Automated Retinal Photography
Showing all 4 trials